Downregulation of the epidermal growth factor receptor by human cytomegalovirus infection in human fetal lung fibroblasts

American Journal of Respiratory Cell and Molecular Biology

Volumn 28, Issue 1, 2003, Pages 86-94

  Beutler, Thomas ^a   Höflich, Conny ^a   Stevens, Paul A ^a   Krüger, Detlev H ^a   Prösch, Susanna ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0037215608     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.4881     Document Type: Article

References (63)

1. Catterton, W. Z., M. B. Escobedo, W. R. Sexson, M. E. Gray, H. W. Sundell, and M. T. Stahlman. 1979. Effect of epidermal growth factor on lung maturation in fetal rabbits. Pediatr. Res. 13:104-108.
2. Nielsen, H. C. 1989. Epidermal growth factor influences the developmental clock regulating maturation of the fetal lung fibroblasts. Biochim. Biophys. Acta 1012:201-206.
3. Whitsett, J. A., T. E. Weaver, M. A. Liebermann, J. C. Clark, and C. Daugherty. 1987. Differential effects of epidermal growth factor and transforming growth factor-beta on synthesis of Mr = 35,000 surfactant-associated protein in fetal lung. J. Biol. Chem. 262:7908-7913.
4. Sen, N., and M. H. Cake. 1991. Enhancement of disaturated phosphatidylcholine synthesis by epidermal growth factor in cultured fetal lung cells involves a fibroblast-epithelial cell interaction. Am. J. Respir. Cell Mol. Biol. 5:337-343.
5. Nielsen, H. C., A. Martin, M. V. Volpe, D. Hatis, and R. J. Vosatka. 1997. Growth factor control of growth and epithelial differentiation in embryonic lungs. Biochem. Mol. Med. 60:38-48.
6. Klein, J. M., L. J. DeWild, and T. A. McCarthy. 1998. Effect of tyrosine kinase inhibition on surfactant protein A gene expression during human lung development. Am. J. Physiol. 274:L542-L551.
7. Klein, J. M., T. A. McCarthy, J. M. Dagle, and J. M. Snyder. 2000. Antisense inhibiton of epidermal growth factor receptor decreases expression of human surfactant protein A. Am. J. Respir. Cell Mol. Biol. 22:676-684.
8. Plopper, C. G., J. A. St.George, L. C. Read, S. J. Nishio, A. J. Weir, L. Edwards, A. F. Tarantal, K. E. Pinkerton, T. A. Merritt, J. A. Whitsett, C. G. Nacimento, and D. Styne. 1992. Acceleration of alveolar type II cell differentiation in fetal rhesus monkey lung by administration of EGF. Am. J. Physiol. 262:L313-L321.
9. Goetzman, B. W., L. C. Read, C. G. Plopper, A. F. Tarantal, C. George-Nascimento, T. A. Merritt, J. A. Whitsett, and D. Styne. 1994. Prenatal exposure to epidermal growth factor attenuates respiratory distress syndrome in Rhesus infants. Pediatr. Res. 35:30-36.
10. Seth, R. L., F. Shum, C. Wu, F. L. Hall, H. C. Slavkin, and D. Warburton. 1993. Role of epidermal growth factor in branching morphogenesis of early mouse embryo lung in culture: Antisense oligonucleotide inhibitory strategy. Dev. Biol. 158:555-559.
11. Yasui, S. A., A. Nagel, A. Oohira, M. Iwashita, and K. Konno. 1993. Effects of anti-mouse EGF antiserum on prenatal lung development in fetal mice. Pediatr. Pulmonol. 15:251-256.
12. Cadena, D. L., and G. N. Nill. 1992. Receptor tyrosine kinases. FASEB J. 6:2332-2337.
13. Lenormand, P., C. Sardet, G. Pages, L. A. G. A. Brunet, and J. Pouyssegur. 1993. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J. Cell Biol. 122:1079-1088.
14. Force, T., and J. V. Bonventre. 1998. Growth factors and mitogen-activated protein kinases. Hypertension 31:152-161
15. Sibilia, M., and E. F. Wagner. 1995. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269:234-238.
16. Miettinen, P. J., J. E. Berger, J. Meneses, Y. Phung, R. A. Pedersen, Z. Werb, and R. Derynck. 1995. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376:337-341.
17. Volpe, M. V., M. Sibilia, E. F. Wagner, and H. C. Nielsen. 1996. Embryonic lung branching morphogenesis, cell proliferation, and differentiation are altered in epidermal growth factor receptor -/- transgenic 129/SV x C57BL/6 mice. Pediatr. Res. 39:70A (Abstr.).
18. Miettinen, P. J., D. Warburton, D. Bu, J. S. Zhao, J. E. Berger, P. Minoo, T. Koivisto, L. Allen, L. Dobbs, Z. Werb, and R. Derynck. 1997. Impaired lung branching morphogenesis in the absence of functional EGF receptor. Dev. Biol. 186:224-236.
19. Lawson, P. R., and K. B. M. Reid. 2000. The roles of surfactant proteins A and D in innate immunity. Immunol. Rev. 173:66-78.
20. Keller, G. H., and R. L. Ladda. 1981. Correlation between phosphatidylcholine labeling and hormone receptor levels in alveolar type II epithelial cells: Effects of dexamethasone and epidermal growth factor. Arch. Biochem. Biophys. 21:321-326.
21. Post, M., and B. T. Smith. 1988. Histochemical and immunocytochemical identification of alveolar type II epithelial cells isolated from fetal rat lung. Am. Rev. Respir. Dis. 137:525-530.
22. Rosenblum, D. A., M. V. Volpe, C. E. L. Dammann, Y. S. Lo, J. F. Thompson, and H. C. Nielsen. 1998. Expression and activity of epidermal growth factor receptor in late fetal rat lung is cell- and sex-specific. Exp. Cell Res. 239:69-81.
23. Alford, C. A., S. Stagno, R. F. Pass, and W. J. Britt. 1990. Congenital and perinatal cytomegalovirus infections. Rev. Infect. Dis. 12:S745-S753.
24. Vochem, M., K. Hamprecht, G. Jahn, and C. P. Speer. 1998. Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr. Infect. Dis. J. 17:53-58.
25. Hamprecht, K., J. Maschmann, M. Vochem, K. Dietz, C. P. Speer, and G. Jahn. 2001. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 357:513-518.
26. Prösch, S., U. Lienicke, C. Priemer, G. Flunker, W. F. Seidel, D. H. Krüger, and R. R. Wauer. 2002. Human adenovirus and human cytomegalovirus infections in preterm newborns: No association with bronchopulmonary dysplasia. Pediatr. Res. 52:119-124.
27. Sawyer, M. H., D. K. Edwards, and S. A. Spector. 1987. Cytomegalovirus infection and bronchopulmonary dysplasia in preterm infants. Am. J. Dis. Child. 141:303-305.
28. Reiterer, F., H. J. Dornbusch, B. Urlesberger, P. Reittner, R. Fotter, M. Zach, H. Popper, and W. Müller. 1999. Cytomegalovirus associated neonatal pneumonia and Wilson-Mikity syndrome: A causal relationship? Eur. Respir. J. 13:460-462.
29. Suzumura, H., K. Sakurai, K. Kano, and T. Ichimura. 1996. Chronic respiratory failure after acquired cytomegalovirus infection in a very low birthweight infant. Acta Pediatr. Jpn. 38:677-680
30. Grundy, J. E., J. D. Shanley, and P. D. Griffith. 1987. Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet 2:996-999.
31. Grundy, J. E. 1990. Virological and pathogenic aspects of cytomegalovirus infection. Rev. Infect. Dis. 12:S711-S719.
32. Podlech, J., R. Holtappels, M. F. Pahl-Seibert, H. P. Steffens, and M. J. Reddehase. 2000. Murine model of interstitial cytomegalovirus pneumonia in syngenic bone marrow transplantation: Persistence of protective pulmonary CDB-T-cells infiltrates after clearance of acute infection. J. Virol. 74:7496-7507.
33. Reddehase, M. J., F. Weiland, K. Münch, S. Jonjic, A. Lüske, and U. H. Koszinowski. 1987. Interstitial murine cytomegalovirus pneumonia after irradiation: Characterization of cells that limit viral replication during established infection in the lungs. J. Virol. 55:264-273.
34. Pitalia, A. K., J. A. Liu-Yin, A. J. Freemont, D. J. Morris, and R. J. Fitzmaurice. 1993. Immunohistological detection of herpes virus 6 in formaline-fixed, paraffin embedded lung tissue. J. Med. Virol. 4:103-107.
35. Plachter, B., C. Sinzger, and G. Jahn. 1996. Cell types involved in replication and distribution of human cytomegalovirus. Adv. Virus Res. 46:195-261.
36. Weyer, C., R. Sabbat, H. Wissel, D. H. Krüger, P. A. Stevens, and S. Prösch. 2000. Surfactant protein A binding to cytomegalovirus proteins enhances virus entry into rat lung cells. Am. J. Respir. Cell Mol. Biol. 23:71-78.
37. Noble, S., and D. Faulds, 1998. Ganciclovir: An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Drugs 56:115-146.
38. Nigro, G., H. Scholz, and U. Bartmann. 1994. Gancyclovir therapy for symptomatic congenital cytomegalovirus infection in infants: A two regimen experience. J. Pediatr. 124:318-322.
39. Whitley, R. J., G. Cloud, W. Gruber, G. A. Storch, G. J. Demmler, R. F. Jacobs, W. Dankner, S. A. Spector, S. Starr, R. F. Pass, S. Stagno, W. J. Britt, C. Alford, Jr., S. J. Soong, X. J. Zhou, L. Sherrill, J. M. FitzGerald, J. P. Sommadossi, and the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. 1997. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: Result of a phase II study. J. Infect. Dis. 175:1080-1086
40. Whitley, R. J. 1999. Therapy of congenital cytomegalovirus infection. J. Clin. Virol. 12:92
41. Barnes, P. J. 1998. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms. Clin. Sci. 94:557-572.
42. Liggins, G. C., and R. N. Howie. 1972. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50:515-525.
43. Tsukahara, H., Y. Watanabe, M. Yasutomi, R. Kobata, S. Tamura, K. Kimura, M. Hiraoka, and M. Mayumi. 1999. Early (4-7 days of age) dexamethasone therapy for prevention of chronic lung disease in preterm infants. Biol. Neonate 76:283-290.
44. Tanaka, J., T. Ogura, S. Kamiya, H. Sato, T. Yoshie, H. Ogura, and M. Hatano. 1984. Enhanced replication of human cytomegalovirus in human fibroblasts treated with dexamethasone. J. Gen. Virol. 65:1759-1767.
45. Leonardi, G. P., and S. M. Lipson. 1992. Enhanced detection of cytomegalovirus in shell vial culture following MRC-5 monolayer pretreatment with glucocorticoids. Zentralbl. Bakteriol. 277:90-99.
46. West, P. G., R. A. Hartwig, and W. W. Baker. 1992. Comparison of sensitivities of three commercial MRC-5 cell lines grown in shell vials of cytomegalovirus and response to enhancing agents. J. Clin. Microbiol. 30:557-560.
47. Damman, C. E., and H. C. Nielsen. 1998. Regulation of the epidermal growth factor receptor in fetal rat lung fibroblasts during late gestation. Endocrinology 139:1671-1677.
48. Clark, J. L., S. Ishii, N. Richert, G. T. Merlino, and I. Pastan. 1985. Epidermal growth factor regulates the expression of its own receptor. Proc. Natl. Acad. Sci. USA 82:8374-8378.
49. Thompson, K. L., and M. R. Rosen. 1989. Regulation of epidermal growth factor receptor gene expression by RA and epidermal growth factor. J. Biol. Chem. 264:3230-3234.
50. Hudson, L. G., J. B. Santon, C. K. Glass, and G. N. Gill. 1990. Ligand-activated thyroid hormone and RA receptors inhibit growth factor receptor promoter expression. Cell 62:1165-1175.
51. Chee, M. A., A. T. Bankier, S. Beck, R. Bohni, C. M. Brown, R. Cerny, T. Horsnell, C. A. Hutchison, III, T. Kouzarides, J. A. Martignetti, E. Preddi, S. C. Satchwell, P. Tomlinson, K. M. Weston, and B. G. Barrell. 1990. Analysis of the protein-coding content of the sequence of human cytomeg-alovirus AD169. Curr. Top. Microbiol. Immunol. 154:125-169.
52. Stinski, M. F., D. R. Thomsen, R. M. Stenberg, and L. C. Goldstein. 1983. Organization and expression of the immediate early genes of human cytomegalovirus. J. Virol. 46:1-14.
53. Recksteiner, M. 1987. Ubiquitin-mediated pathways for intracellular proteolysis. Annu. Rev. Cell Biol. 87:31-36.
54. Hagemeier, C., S. Walker, R. Caswell, T. Kouzarides, and J. Sinclair. 1992. The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID. J. Virol. 66:4452-4456.
55. Greaves, R. F., and E. S. Mocarski. 1998. Defective growth correlates with reduced accumulation of a viral DNA replication protein after low multiplicity infection by a human cytomegalovirus ie1 mutant. J. Virol. 72:366-379.
56. Mocarski, E. S., G. W. Kemble, J. M. Lyle, and R. F. Greaves. 1996. A deletion mutant in the human cytomegalovirus gene encoding IE1 (491aa) is replication defective due to failure in autoregulation. Proc. Natl. Acad. Sci. USA 93:11321-11326.
57. Marchinin, A., H. Liu, and H. Zhu. 2001. Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J. Virol. 75:1870-1878.
58. Simmen, K. A., J. Singh, B. G. M. Luukkonen, M. Lopper, A. Bittner, N. E. Miller, M. R. Jackson, T. Compton, and K. Früh. 2001. Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc. Natl. Acad. Sci. USA 98:7140-7145.
59. Vallejo, J. G., J. A. Englund, J. A. Garcia-Prats, and G. J. Demmler. 1994. Ganciclovir treatment of steroid-associated cytomegalovirus disease in a congenitally infected neonate. Pediatr. Infect. Dis. J. 13:239-241.
60. Carlin, C. R., A. E. Tollefson, H. A. Brady, B. L. Hoffman, and W. S. M. Wold. 1989. Epidermal growth factor receptor is down-regulated by a 10,400 MW protein encoded by the E3 region of adenovirus. Cell 57:135-144.
61. Tollefson, A. E., A. R. Stewart, S. P. Yei, S. K. Saha, and W. S. M. Wold. 1991. The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor. J. Virol. 65:3095-3105.
62. Brown, J. P., D. R. Twardzik, H. Marquardt, and G. J. Todaro. 1985. Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor. Nature 313:491-492.
63. Twardzik, D. R., J. P. Brown, J. E. Ranchalis, G. J. Todaro, and B. Moss. 1985. Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors. Proc. Natl. Acad. Sci. USA 82:5300-5304.